Home › GSK receives European and CHMP approval for stem cell gene therapy
 

Keywords :   


GSK receives European and CHMP approval for stem cell gene therapy

2016-04-02 23:10:57| Biotech - Topix.net

GlaxoSmithKline has been given encouraging support for a stem cell gene therapy that uses an individual patient's own cells to treat a very rare immunodeficiency disorder in children. The Committee for Medicinal Products for Human Use of the European Medicines Agency , in conjunction with the Committee for Advanced Therapies , has issued a positive opinion recommending marketing authorisation for Strimvelis, GSK's brand name for the medicine to treat the ADA-SCID disorder.

Tags: cell european approval therapy

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
More »